Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 Env antibody elicited by DNA priming and protein boosting

被引:108
作者
Richmond, JFL
Lu, S
Santoro, JC
Weng, J
Hu, SL
Montefiori, DC
Robinson, HL
机构
[1] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA
[2] Univ Massachusetts, Sch Med, Dept Infect Dis, Worcester, MA USA
[3] Univ Washington, Reg Primate Res Ctr, Seattle, WA 98195 USA
[4] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA
[5] Duke Univ, Med Ctr, Ctr AIDS Res, Durham, NC USA
关键词
D O I
10.1128/JVI.72.11.9092-9100.1998
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
DNA vaccination is an effective means of eliciting strong antibody responses to a number of viral antigens. However, DNA immunization alone has not generated persistent, high-titer antibody and neutralizing antibody responses to human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein (Env). We have previously reported that DNA-primed anti-Env antibody responses can be augmented by boosting with Env-expressing recombinant vaccinia viruses. We report here that recombinant Env protein provides a more effective boost of DNA-initiated antibody responses. In rabbits primed with Env-expressing plasmids, protein boosting increased titer, persistence, neutralizing activity, and avidity of anti-Env responses. While titers increased rapidly after boosting, avidity and neutralizing activity matured more slowly over a 6-month period following protein boosting. DNA priming and protein immunization with HIV-1 HXB-2 Env elicited neutralizing antibody for T cell line-adapted, but not primary isolate, viruses. The most effective neutralizing antibody responses were observed after priming with plasmids which expressed noninfectious virus-like particles. In contrast to immunizations with HIV-1 Env, DNA immunizations with the influenza virus hemagglutinin glycoprotein did not require a protein boost to achieve high-titer antibody with good avidity and persistence.
引用
收藏
页码:9092 / 9100
页数:9
相关论文
共 66 条
[1]   Vaccination with HIV 1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit [J].
Barnett, SW ;
Rajasekar, S ;
Legg, H ;
Doe, B ;
Fuller, DH ;
Haynes, JR ;
Walker, CM ;
Steimer, KS .
VACCINE, 1997, 15 (08) :869-873
[2]   An investigation of the high-avidity antibody response to glycoprotein 120 of human immunodeficiency virus type 1 [J].
Binley, JM ;
Arshad, H ;
Fouts, TR ;
Moore, JP .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (12) :1007-1015
[3]   Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1 [J].
Binley, JM ;
Klasse, PJ ;
Cao, YZ ;
Jones, I ;
Markowitz, M ;
Ho, DD ;
Moore, JP .
JOURNAL OF VIROLOGY, 1997, 71 (04) :2799-2809
[4]   Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination [J].
Boyer, JD ;
Ugen, KE ;
Wang, B ;
Agadjanyan, M ;
Gilbert, L ;
Bagarazzi, ML ;
Chattergoon, M ;
Frost, P ;
Javadian, A ;
Williams, WV ;
Refaeli, Y ;
Ciccarelli, RB ;
McCallus, D ;
Coney, L ;
Weiner, DB .
NATURE MEDICINE, 1997, 3 (05) :526-532
[5]   Role of different lymphoid tissues in the initiation and maintenance of DNA-raised antibody responses to the influenza virus H1 glycoprotein [J].
Boyle, CM ;
Morin, M ;
Webster, RG ;
Robinson, HL .
JOURNAL OF VIROLOGY, 1996, 70 (12) :9074-9078
[6]   ANTIGENIC IMPLICATIONS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE QUATERNARY STRUCTURE - OLIGOMER-SPECIFIC AND OLIGOMER-SENSITIVE MONOCLONAL-ANTIBODIES [J].
BRODER, CC ;
EARL, PL ;
LONG, D ;
ABEDON, ST ;
MOSS, B ;
DOMS, RW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (24) :11699-11703
[7]  
CHAROENVIT Y, 1990, B WORLD HEALTH ORGAN, V68, P26
[8]   CROSS-PROTECTIVE IMMUNE-RESPONSES INDUCED IN RHESUS MACAQUES BY IMMUNIZATION WITH ATTENUATED MACROPHAGE-TROPIC SIMIAN IMMUNODEFICIENCY VIRUS [J].
CLEMENTS, JE ;
MONTELARO, RC ;
ZINK, MC ;
AMEDEE, AM ;
MILLER, S ;
TRICHEL, AM ;
JAGERSKI, B ;
HAUER, D ;
MARTIN, LN ;
BOHM, RP ;
MURPHEYCORB, M .
JOURNAL OF VIROLOGY, 1995, 69 (05) :2737-2744
[9]   Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity [J].
Cole, KS ;
Rowles, JL ;
Jagerski, BA ;
MurpheyCorb, M ;
Unangst, T ;
Clements, JE ;
Robinson, J ;
Wyand, MS ;
Desrosiers, RC ;
Montelaro, RC .
JOURNAL OF VIROLOGY, 1997, 71 (07) :5069-5079
[10]   HUMAN STUDIES IN THE DEVELOPMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS VACCINES [J].
DOLIN, R .
JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (05) :1175-1183